Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multimodal Imaging in NSCLC N-stage
NCT05840094Unknown
- Sponsor
- Peking University First Hospital
- Start
- May 2023
- Primary completion
- May 2025
- Countries
- 1
01
Overview
Randomised, open-label trial (3 arms), sponsored by Peking University First Hospital. Primary endpoint: Diagnostic efficacy of 18F-FDG PET/CT and MR STIR sequences combined with EBUS-TBNA at 1 year. Status: unknown.
Beyond the preview
Go deeper on NCT05840094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05840094.